Clinical Trials

Folic acid has been evaluated in numerous clinical trials and non-interventional studies spanning Phase 1 through Phase 4 evaluations across hematologic, neurological, and structural birth defect indications. Prominent institutional sponsors, including The University of Hong Kong, Queen's University, Beni-Suef University, Xuzhou Medical University, and the University of Iowa, have driven these investigations across completed, active, recruiting, and withdrawn protocols. Overall, these trials reflect sustained clinical interest in assessing folic acid supplementation for conditions ranging from deficiency anemias and pediatric vaso-occlusive crises to oral cleft prevention.

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT07113158 NOT_YET_RECRUITING
Sudden Sensorineural Hearing Loss
Assistance Publique - Hôpitaux de Paris
2026-04-01 PHASE3
NCT06641245 NOT_YET_RECRUITING
Folate; Folate Bioavailability; Clinical Trials; Pregnancy
University of British Columbia
2025-01-31
NCT07241221 RECRUITING
Perinatal and Neonatal Outcomes in Pregnancies With Type 2 Diabetes Mellitus (T2DM)
National University Hospital, Singapore
2025-12
NCT07695883 NOT_YET_RECRUITING
Neurodevelopment Outcome; Linear Growth; Micronutrient Status; Bone Mineral Density; Underweight; Stunting; Body Composition; Blood Pressure; HRQOL (Health Related Quality Of Life); Waist-to-height Ratio
Johns Hopkins Bloomberg School of Public Health
2026-10-01 PHASE3
NCT07697196 NOT_YET_RECRUITING
HPV Infection; HPV Integration; HPV Disease; HPV Genital Infection; HPV Persistence; Low Grade Squamous Intraepithelial Lesions of the Cervix
IRCCS San Raffaele
2026-07
NCT07680595 RECRUITING
Carotid Atherosclerotic Plaque
Ruijin Hospital
2026-03-01 PHASE1; PHASE2
NCT07344337 NOT_YET_RECRUITING
HPV Infection; Infertilities
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
2026-03
NCT05096663 ACTIVE_NOT_RECRUITING
Advanced Lung Non-Small Cell Carcinoma; Recurrent Lung Non-Small Cell Carcinoma; Stage III Lung Cancer AJCC v8; Stage IIIA Lung Cancer AJCC v8; Stage IIIB Lung Cancer AJCC v8; Stage IIIC Lung Cancer AJCC v8; Stage IV Lung Cancer AJCC v8; Stage IVA Lung Cancer AJCC v8; Stage IVB Lung Cancer AJCC v8
SWOG Cancer Research Network
2022-03-15 PHASE2; PHASE3
NCT06734611 RECRUITING
Folate Deficiency; Neural Tube Defects
University of Alabama at Birmingham
2026-04-10
NCT07013136 NOT_YET_RECRUITING
Acute Kidney Injury
The University of Hong Kong
2025-10-01 EARLY_PHASE1
NCT01687127 NOT_YET_RECRUITING
One-carbon Metabolism in Healthy Individuals
University of British Columbia
2024-01-01
NCT07648251 NOT_YET_RECRUITING
Severe Preeclampsia
Universidad Nacional Autonoma de Honduras
2026-06-15 PHASE2
NCT07665957 NOT_YET_RECRUITING
Maternal Anemia; Micronutrient Deficiency; Pregnancy Outcomes; Maternal Nutrition
Sindh Institute of Child Health and Neonatology
2026-06-25
NCT04579848 ACTIVE_NOT_RECRUITING
Hand Osteoarthritis; Erosive Osteoarthritis
Diakonhjemmet Hospital
2021-08-12 PHASE4
NCT07661602 NOT_YET_RECRUITING
Anemia
Southern Medical University, China
2026-07 PHASE3
NCT05612984 WITHDRAWN
Preterm Labor; Small for Gestational Age at Delivery; Hypertensive Disorder of Pregnancy; Low Birth Weight; Neonatal Death
Johns Hopkins Bloomberg School of Public Health
2024-04-01 PHASE3
NCT05284656 ACTIVE_NOT_RECRUITING
Chronic Kidney Diseases
Al-Azhar University
2022-01-08 PHASE3
NCT06768294 NOT_YET_RECRUITING
Calcium Pyrophosphate Deposition Disease; Chondrocalcinosis
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
2025-01 PHASE2
NCT07540130 ACTIVE_NOT_RECRUITING
Pregnant Women; Pregnant Women and Their Offspring
National Institute of Neurosciences and Hospital, Dhaka
2025-02-11 PHASE1; PHASE2
NCT04024254 COMPLETED
Ovarian Cancer; Breast Cancer; Folic Acid Deficiency
Rush University Medical Center
2020-07-21 PHASE4
NCT07725549 COMPLETED
Maternal Micronutrient Status; Pregnancy; Low Birth Weight; Maternal Anemia
Indonesia Timur University
2025-07-10
NCT07029698 COMPLETED
Vitamin B12 Deficiency
Medice Arzneimittel Pütter GmbH & Co KG
2025-04-16 PHASE4
NCT04310059 UNKNOWN
Thalassemia; Folic Acid Deficiency Anemia
The University of Hong Kong
2024-07-01
NCT06327646 ACTIVE_NOT_RECRUITING
Supplementation
Helen Keller International
2024-07-04
NCT05378919 RECRUITING
Neoadjuvant Therapy in Rectal Cancer, Radiotherapy, FOLFOX
Lithuanian University of Health Sciences
2015-06-01 PHASE2
NCT06936215 RECRUITING
Diffuse Cutaneous Systemic Sclerosis
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
2024-01-01 PHASE3
NCT06175338 ACTIVE_NOT_RECRUITING
Rheumatoid Arthritis
Mabscale, LLC
2023-06-14 PHASE1
NCT04310059 Not yet recruiting
Thalassemia|Folic Acid Deficiency Anemia
The University of Hong Kong|Queen Mary Hospital Hong Kong
2024-07-01 Not Applicable
NCT06218030 Not yet recruiting
Generalized Anxiety Disorder
Queen''s University
2024-04 Phase 4
NCT06314932 Not yet recruiting
Overweight
University of Milan|University of Florence|University of Teramo
2024-04 Not Applicable
NCT04786964 TERMINATED
Metastatic Non-squamous Non Small Cell Lung Cancer
Checkpoint Therapeutics, Inc.
2021-12-08 PHASE3
NCT05524259 UNKNOWN
Gestational Diabetes Mellitus; Preeclampsia; Preterm Birth; Polycystic Ovary Syndrome
Erasmus Medical Center
2019-06-21
NCT05312242 COMPLETED
Adherence, Medication
Johns Hopkins Bloomberg School of Public Health
2022-02-10
NCT04228263 COMPLETED
Unexplained Recurrent Miscarriage
Assiut University
2020-01-01
NCT04989049 UNKNOWN
Oral Ulcer
Dow University of Health Sciences
2022-09 EARLY_PHASE1
NCT05097365 ENROLLING_BY_INVITATION
Overweight and Obesity; Lupus Erythematosus
University of Sao Paulo
2022-01-01
NCT04880499 COMPLETED
Orthopedic Disorder; Hip Arthropathy; Knee Arthropathy; Anemia; Iron Poor Blood
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
2021-04-21
NCT04782037 UNKNOWN
Diarrhoea;Acute
King Edward Medical University
2020-10-21 PHASE4
NCT05943158 COMPLETED
Pregnancy Related
Near East University, Turkey
2021-06-01
NCT03533712 COMPLETED
Small for Gestational Age at Delivery; Low Birth Weight; Prematurity; Infant Malnutrition
University Ghent
2019-10-30 PHASE4
NCT03823248 UNKNOWN
Gastric Precancerous Condition
Xiyuan Hospital of China Academy of Chinese Medical Sciences
2019-03-01 PHASE1; PHASE2
NCT04265534 TERMINATED
Non-Small Cell Lung Cancer; Non-squamous Non-small-cell Lung Cancer; Non-Squamous Non-Small Cell Neoplasm of Lung; KEAP1 Gene Mutation; NRF2 Gene Mutation; NFE2L2 Gene Mutation
Calithera Biosciences, Inc
2020-07-24 PHASE2
NCT03485404 TERMINATED
Post Operative Cognitive Dysfunction
Xijing Hospital
2019-01-10
NCT05455073 COMPLETED
Anemia; Menstrual Hygiene Management; Improved Water, Sanitation and Hygiene (WASH)
Nutrition International
2019-07-31
NCT03994731 COMPLETED
Gout
Amgen
2019-06-13 PHASE4
NCT03516903 TERMINATED
Myocardial Infarction, Anterior Wall; Myocardial Remodeling, Ventricular
University of Sao Paulo
2018-04-17 PHASE2; PHASE3
NCT04301336 COMPLETED
Vaso-occlusive Crisis; Sickle Cell Disease; Sickle Cell Anemia in Children
Beni-Suef University
2019-11-01 PHASE2; PHASE3
NCT04066803 UNKNOWN
Rheumatoid Arthritis
Sun Yat-sen University
2018-08-01 PHASE4
NCT04645745 COMPLETED
Polycystic Ovary Syndrome
AGUNCO Obstetrics and Gynecology Centre
2019-06-15
NCT02537392 COMPLETED
Congenital Heart Disease
Xi'an Jiaotong University
2015-09
NCT02302326 COMPLETED
Polycystic Ovary Syndrome
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana
2013-01
NCT03193788 UNKNOWN
Bladder Cancer; Ureter Cancer; Transitional Cell Carcinoma
Asan Medical Center
2017-01 PHASE3
NCT04952051 COMPLETED
Hypertension
Second Affiliated Hospital, Zhejiang University, School of Medicine
2014-07-01 PHASE3
NCT04019899 COMPLETED
Female Infertility
Lo.Li.Pharma s.r.l
2018-05-02
NCT03950674 COMPLETED
Non-Small-Cell Lung Carcinoma
Merck Sharp & Dohme LLC
2016-02-22 PHASE3
NCT03384862 COMPLETED
Arsenic Exposure
Columbia University
2018-01-27
NCT03674333 UNKNOWN
Dyslipidemias
Shaheed Zulfiqar Ali Bhutto Medical University
2018-09-24
NCT02344888 UNKNOWN
Infertility; Polycystic Ovarian Syndrome
Mahmoud Thabet
2015-02 PHASE4
NCT03766594 COMPLETED
Miscarriage, Recurrent
Ain Shams University
2018-01-01 PHASE1
NCT02916121 UNKNOWN
Schizophrenia
Taipei Medical University WanFang Hospital
2016-10
NCT03332602 COMPLETED
Iron-deficiency
Swiss Federal Institute of Technology
2018-04-04
NCT03306745 COMPLETED
Polycystic Ovary Syndrome; Infertility, Female; Micronutrient Deficiency
Medical University of Vienna
2017-06-02
NCT03595163 UNKNOWN
Sevoflurane; Propofol; Homocysteine; Cochlear Hearing Loss
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
2018-01-01
NCT03481790 COMPLETED
Iron Deficiency Anemia of Pregnancy
Ain Shams Maternity Hospital
2017-09-01 PHASE2
NCT01999738 COMPLETED
Solid Tumors; Non Small Cell Lung Carcinoma
Endocyte
2013-10 PHASE1
NCT03011320 COMPLETED
Ovary Cancer
Endocyte
2017-01-24 PHASE1
NCT00970866 COMPLETED
Anemia; Malnutrition; Stunting
University of California, Davis
2009-11
NCT02578680 COMPLETED
Non-Small-Cell Lung Carcinoma
Merck Sharp & Dohme LLC
2016-01-15 PHASE3
NCT03040219 UNKNOWN
Primary Malnurtrition
Ain Shams University
2017-04-01 PHASE4
NCT02786823 COMPLETED
Diabetes Mellitus, Type 2
All India Institute of Medical Sciences, Bhubaneswar
2017-05-01 PHASE2; PHASE3
NCT02437721 COMPLETED
Growth and Development
dsm-firmenich Switzerland AG
2015-05
NCT02908581 COMPLETED
Chronic Arsenic Poisoning
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
2016-06 PHASE2
NCT02644499 COMPLETED
Rheumatoid Arthritis
Jawaharlal Institute of Postgraduate Medical Education & Research
2015-12-31 PHASE4
NCT02467504 COMPLETED
Rheumatoid Arthritis
Peking University People's Hospital
2015-07-01 PHASE2
NCT01953536 WITHDRAWN
Breast Neoplasms
Endocyte
2014-04 PHASE2
NCT01248260 COMPLETED
Fetal Body Size; Fetal Brain Size
Hamisu Salihu
2011-02
NCT01355159 COMPLETED
Pregnancy Complications; Preeclampsia
Ottawa Hospital Research Institute
2011-04 PHASE3
NCT01188876 COMPLETED
Ovarian Cancer; Fallopian Tube Cancer; Peritoneal Cancer
Massachusetts General Hospital
2010-08 PHASE1; PHASE2
NCT02393378 TERMINATED
Rheumatoid Arthritis
Takeda
2015-04-08 PHASE2
NCT01317849 WITHDRAWN
Stroke; Transient Ischemic Attack
Xijing Hospital
2011-07
NCT01407432 COMPLETED
Male Infertility
Assistance Publique - Hôpitaux de Paris
2011-11 PHASE3
NCT02610881 COMPLETED
Anemia
Emory University
2015-12
NCT02124642 COMPLETED
Pregnancy
University of Georgia
2014-05
NCT01134341 COMPLETED
Cutaneous T-cell Lymphoma; Mycosis Fungoides; Sezary Syndrome; Primary Cutaneous Anaplastic Large Cell Lymphoma
Acrotech Biopharma Inc.
2010-03 PHASE1
NCT01841658 COMPLETED
Obesity
University of Georgia
2013-04
NCT02651636 COMPLETED
Polycystic Ovary Syndrome; Menstrual Pattern; Hyperandrogenism; Metabolic Features
Catholic University of the Sacred Heart
2014-06
NCT02730949 COMPLETED
Type 1 Diabetes
Campus Bio-Medico University
2014-03 PHASE3
NCT00973609 COMPLETED
Colorectal Neoplasms
AIO-Studien-gGmbH
2009-08 PHASE3
NCT01873443 COMPLETED
Rheumatoid Arthritis
Celltrion
2013-05 PHASE1
NCT02079948 WITHDRAWN
Inflammation; Aging
University of Florida
2014-02 PHASE2
NCT01665378 COMPLETED
Anemia; Intrauterine Growth Retardation; Preterm Delivery; Iron Deficiency
Emory University
2011-10
NCT01921192 UNKNOWN
Non Proliferative Diabetic Retinopathy; Proliferative Diabetic Retinopathy
University of Catania
2012-09 PHASE4
NCT01555190 COMPLETED
Polycystic Ovary Syndrome; Hirsutism; Menstrual Irregularity
Catholic University of the Sacred Heart
2012-01
NCT01956786 UNKNOWN
Essential Hypertension
Shenzhen Ausa Pharmed Co.,Ltd
2013-09 PHASE2; PHASE3
NCT01850680 COMPLETED
Rheumatoid Arthritis
Sanofi
2013-04 PHASE1
NCT01210040 COMPLETED
Malaria
Liverpool School of Tropical Medicine
2011-04
NCT03359057 COMPLETED
Contraception
Galeno Desenvolvimento de Pesquisas Clínicas
2013-02-26 PHASE3
NCT01856348 COMPLETED
Physiological Effects of Vitamin D
University of Zurich
2013-05 PHASE1
NCT01047982 COMPLETED
Gestational Diabetes
University of Messina
2010-03
NCT00923273 TERMINATED
Carcinoma, Non-Small-Cell Lung
National Cancer Institute (NCI)
2008-02-29 PHASE1; PHASE2
NCT00696514 UNKNOWN
Osteoporosis; Cognitive Decline
Wageningen University
2008-09 PHASE1
NCT03522428 COMPLETED
Pregnancy Anemia
Mirela Zec
2011-09-15 PHASE4
NCT01263080 COMPLETED
Schizophrenia
Capital Medical University
2010-11 PHASE4
NCT01608750 UNKNOWN
Nonulcer Dyspepsia
Bezmialem Vakif University
2012-06 PHASE4
NCT01828710 COMPLETED
Asthenozoospermia; Oligospermia
AGUNCO Obstetrics and Gynecology Centre
2012-08
NCT01490944 UNKNOWN
Anaemia
Indian Council of Medical Research
2012-01 PHASE2
NCT00397917 COMPLETED
Cleft Lip; Cleft Palate
University of Iowa
2006-11 PHASE3
NCT01116141 COMPLETED
Rheumatoid Arthritis
Chelsea Therapeutics
2010-09 PHASE2
NCT00554827 COMPLETED
Cutaneous T-cell Lymphoma
Acrotech Biopharma Inc.
2007-08 PHASE1
NCT00064753 COMPLETED
Chronic Kidney Disease; Cardiovascular Disease; Death
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
2002-05 PHASE2; PHASE3
NCT00717730 COMPLETED
Diarrhea; Pneumonia
Tor A. Strand
2010-01 PHASE2
NCT00806819 COMPLETED
Carcinoma, Non-Small-Cell Lung
Boehringer Ingelheim
2008-12 PHASE3
NCT00481871 COMPLETED
Relapsed or Refractory Lymphoproliferative Malignancies; Hodgkin's Lymphoma; Peripheral T-cell Lymphoma; B-cell Lymphoma; Waldenstrom's Macroglobulinemia
Acrotech Biopharma Inc.
2007-05 PHASE1; PHASE2
NCT00722553 COMPLETED
Carcinoma, Transitional Cell; Bladder Cancer; Bladder Neoplasm
Acrotech Biopharma Inc.
2008-07 PHASE2
NCT01010581 COMPLETED
Rheumatoid Arthritis
4SC AG
2009-11 PHASE2
NCT00730574 TERMINATED
B12 Deficiency Combined With C677T Mutation on MTHFR Gene
Moshe Flugelman
2008-07
NCT00950989 COMPLETED
Rheumatoid Arthritis
Amgen
2009-12-30 PHASE2
NCT01194453 COMPLETED
Non-small Cell Lung Cancer; Efficacy
Sun Yat-sen University
2009-11 PHASE2
NCT00217100 COMPLETED
Kidney Transplant Recipients
Mayo Clinic
2004-10 PHASE3
NCT00901394 COMPLETED
Cardiovascular Abnormalities
Washington University School of Medicine
2009-03
NCT03221816 COMPLETED
Menopause; Dyslipidemias; Homocystinaemia
Casa de Saúde santa Marcelina
2008-12 PHASE4
NCT00578305 COMPLETED
Rheumatoid Arthritis
Hoffmann-La Roche
2007-11 PHASE3
NCT00781196 COMPLETED
Gingival Overgrowth
All India Institute of Medical Sciences
2008-05 PHASE3
NCT06516081 COMPLETED
Anemia
The Hospital for Sick Children
2005-09
NCT00330915 COMPLETED
Rectal Neoplasms
Eli Lilly and Company
2006-06 PHASE2
NCT01258660 COMPLETED
Contraception
Bayer
2006-12 PHASE1
NCT00372645 COMPLETED
Healthy
Quadram Institute Bioscience
2005-05
NCT00116493 COMPLETED
Anemia
Johns Hopkins Bloomberg School of Public Health
2004-04 PHASE3
NCT00114400 COMPLETED
Atherosclerosis
National Institute on Aging (NIA)
2000-11 PHASE2; PHASE3
NCT04731948 COMPLETED
Healthy
University of Ulster
2004-10-01
NCT00680732 COMPLETED
Malaria; Malaria in Pregnancy
Institute of Tropical Medicine, Belgium
2003-06 PHASE4
NCT00202280 COMPLETED
First Episode Psychosis
Melbourne Health
2004-09 PHASE2; PHASE3
NCT00611000 COMPLETED
Colorectal Cancer
Rockefeller University
2003-06 PHASE1
NCT00512850 COMPLETED
Adenoma of Large Intestine
Brigham and Women's Hospital
1996-05
NCT00822380 COMPLETED
Anemia
Universidad Autonoma de Queretaro
2003-03
NCT00269542 COMPLETED
Morbidity; Mortality; Diarrhea; Pneumonia
Society for Applied Studies
2002-02
NCT00003763 COMPLETED
Ovarian Cancer
Endocyte
1997-12-08
NCT00807807 COMPLETED
Heart Diseases
National Heart, Lung, and Blood Institute (NHLBI)
1996-06 PHASE3
NCT00111267 COMPLETED
Cognitive Decline; Cognitive Symptoms
Wageningen University
2003-05
NCT00709332 COMPLETED
Drug Interactions; Contraception; Pharmacokinetics
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
2005-01 PHASE1
NCT00570856 TERMINATED
Kidney Transplantation
Shahid Beheshti University of Medical Sciences
2005-06 PHASE4
NCT00126347 COMPLETED
Healthy; Cardiovascular Diseases
Wageningen Centre for Food Sciences
2002-08
NCT01560065 COMPLETED
Sperm Quality; Oligoasthenospermia
AGUNCO Obstetrics and Gynecology Centre
PHASE4
NCT00709189 COMPLETED
Female Contraception; Contraception; Therapeutic Equivalency; Pharmacokinetics
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
2005-05 PHASE1
NCT00170404 COMPLETED
Mycobacterium Tuberculosis
National Institute of Allergy and Infectious Diseases (NIAID)
2000-06 PHASE3
NCT00314990 COMPLETED
Deep-Vein Thrombosis; Pulmonary Embolism
Radboud University Medical Center
1996-01
NCT00470522 COMPLETED
Systemic Lupus Erythematosus
University Health Network, Toronto
1995-06 PHASE3
NCT00709982 COMPLETED
Drug Interactions; Healthy; Pharmacokinetics
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
2005-05 PHASE1
NCT00491907 TERMINATED
Heart Failure
University of Zurich
2004-10 PHASE4
NCT00709267 COMPLETED
Healthy; Pharmacokinetics
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
2004-10 PHASE1
NCT00033722 UNKNOWN
Lung Cancer
Tularik
2002-02 PHASE2
NCT00120822 COMPLETED
Malaria
London School of Hygiene and Tropical Medicine
2002-07 PHASE3
NCT00520247 COMPLETED
Plasma Total Homocysteine Level; Blood Pressure
Anhui Medical University
2005-09 PHASE2
NCT01511835 UNKNOWN
Gestational Diabetes
AGUNCO Obstetrics and Gynecology Centre
PHASE4

(data from https://clinicaltrials.gov, updated on 2026-01-14)

Check the Folic acid product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.

Compliance for Clinical Use

Mechanism and Biochemical Profile

Folic acid serves as an essential precursor converted intracellularly into tetrahydrofolate coenzymes that mediate one-carbon transfer reactions required for purine, pyrimidine, and amino acid biosynthesis. By supporting essential nucleic acid synthesis and cellular methylation pathways during active cell division, folic acid prevents DNA strand breakage and nucleotide depletion, providing therapeutic efficacy in managing deficiency anemias, developmental malformations, and related hematologic disorders.

Appendix RUO and cGMP Quality Standards

Quality Dimension RUO (Research Use Only) cGMP (Current Good Manufacturing Practice)
Clinical Applicability Prohibited in human clinical trials or medical diagnostics. Mandatory for human clinical trials (Phase I–III) and therapies.
Regulatory Status Non-regulated grade; exempt from drug manufacturing laws. Legally enforced by health authorities (e.g., FDA, EMA, NMPA).
Facility Environment Unclassified analytical or research laboratories. Validated Cleanrooms (ISO Class 5–8) with continuous monitoring.
Quality Control Basic purity and activity testing. Rigorous safety release testing (Sterility, Endotoxin, Mycoplasma).
Process Validation Basic equipment calibration; no process validation required. Full qualification (IQ/OQ/PQ) and complete batch records.
Quality Assurance Vendor self-declared without required formal QMS. Mandatory QA/QC unit, Change Control, CAPA, and vendor audits.
Regulatory Impact High risk of IND rejection if used as a critical raw material. Required for IND/NDA filings, supported by Drug Master Files (DMF).

Footnotes

Regulatory Note: Governed by FDA (21 CFR Parts 210/211/312), EMA (EudraLex Vol 4), ICH Guidelines (E6/Q7/Q9/Q10), and compendial standards (USP <71>/<85>/<1043>).

Note: Technical data last updated: Sep 1, 2026.